KIT and systemic mastocytosis: Additional KIT mutations as well as KIT-independent pathways (e.g., Lyn and Btk) have recently been implicated in the pathogenesis of SM (Gleixner et al. 2011; Schwaab et al. 2013; Orfao et al. 2007).